// App-Quantinova.ai

: Higher Proportions of Monocytic-Myeloid-Derived Suppressive Cells (mMDSC) before Allotransplant Predict Relapse in Acute Leukemia Patients

Researchers

Presenter

  • Pierre Peterlin

Principal Investigators

  • Marie C Bene

  • Maxime Jullien

  • Thierry Guillaume

  • Amandine Le Bourgeois

  • Alice Garnier

  • Camille Debord

  • Marion Eveillard

  • Patrice Chevallier

Medical Centers

  • Hematology Biology, Nantes University Hospital, Nantes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Acute Leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 14

  • Cluster of differentiation 45

  • Human Leukocyte Antigen – DR isotype

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved